Your browser doesn't support javascript.
loading
Fewer LAG-3+ T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes.
Jones, Britta E; Maerz, Megan D; Bahnson, Henry T; Somasundaram, Ashwin; McCarthy, Lucas H; Speake, Cate; Buckner, Jane H.
Afiliação
  • Jones BE; Translational Research Program, Benaroya Research Institute, Seattle, WA.
  • Maerz MD; Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA.
  • Bahnson HT; Center for Interventional Immunology, Benaroya Research Institute, Seattle, WA; and.
  • Somasundaram A; Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • McCarthy LH; Center for Interventional Immunology, Benaroya Research Institute, Seattle, WA; and.
  • Speake C; Center for Interventional Immunology, Benaroya Research Institute, Seattle, WA; and.
  • Buckner JH; Translational Research Program, Benaroya Research Institute, Seattle, WA; jbuckner@benaroyaresearch.org.
J Immunol ; 208(3): 594-602, 2022 02 01.
Article em En | MEDLINE | ID: mdl-35022272
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Antígenos CD / Linfócitos T CD8-Positivos / Esclerose Múltipla Recidivante-Remitente / Diabetes Mellitus Tipo 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Antígenos CD / Linfócitos T CD8-Positivos / Esclerose Múltipla Recidivante-Remitente / Diabetes Mellitus Tipo 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article